Artem Silchenko

Dr. Artem Silchenko

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
ASArtem Silchenko
Artem Silchenko
ARAnton B. Rasin
Anton B. Rasin
MKMikhail Kusaykin
Mikhail Kusaykin
AKAnatoly I. Kalinovsky
Anatoly I. Kalinovsky
ZMZhang Miansong
Zhang Miansong
SESvetlana P. Ermakova
Svetlana P. Ermakova

22 April 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
NKNatalya Krylova
Natalya Krylova
SESvetlana Ermakova
Svetlana Ermakova
VLVyacheslav F. Lavrov
Vyacheslav F. Lavrov
ILIrina Leneva
Irina Leneva
GKGalina Kompanets
Galina Kompanets
TZTatyana S. Zaporozhets
Tatyana S. Zaporozhets
The enzymatic depolymerization of fucoidans from brown algae allowed the production of their standardized derivatives with different biological activities. This work aimed to compare the antiviral activities of native (FeF) and modified with enzyme (FeHMP) fucoidans from F. evanescens. The cytotoxicity and antiviral activities of the FeF and FeHMP against herpes viruses (HSV-1, HSV-2), enterovirus (ECHO-1), and human immunodeficiency virus (HIV-1) in Vero and human MT-4 cell lines were examined by methylthiazolyltetrazolium bromide (MTT) and cytopathic effect (CPE) reduction assays, respectively. The efficacy of fucoidans in vivo was evaluated in the outbred mice model of vaginitis caused by HSV-2. We have shown that both FeF and FeHMP significantly inhibited virus-induced CPE in vitro and were more effective against HSV. FeF exhibited antiviral activity against HSV-2 with a selective index (SI) > 40, and FeHMP with SI ˃ 20, when they were added before virus infection or at the early stages of the HSV-2 lifecycle. Furthermore, in vivo studies showed that after intraperitoneal administration (10 mg/kg), both FeF and FeHMP protected mice from lethal intravaginal HSV-2 infection to approximately the same degree (44–56%). Thus, FeF and FeHMP have comparable potency against several DNA and RNA viruses, allowing us to consider the studied fucoidans as promising broad-spectrum antivirals.

11 July 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ASArtem Silchenko
Artem Silchenko
MKMikhail Kusaykin
Mikhail Kusaykin
VKValeriya Kurilenko
Valeriya Kurilenko
AZAlexander Zakharenko
Alexander Zakharenko
VIVladimir V. Isakov
Vladimir V. Isakov
TZTatyana N. Zvyagintseva
Tatyana N. Zvyagintseva
Intracellular fucoidanase was isolated from the marine bacterium, Formosa algae strain KMM 3553. The first appearance of fucoidan enzymatic hydrolysis products in a cell-free extract was detected after 4 h of bacterial growth, and maximal fucoidanase activity was observed after 12 h of growth. The fucoidanase displayed maximal activity in a wide range of pH values, from 6.5 to 9.1. The presence of Mg2+, Ca2+ and Ba2+ cations strongly activated the enzyme; however, Cu2+ and Zn2+ cations had inhibitory effects on the enzymatic activity. The enzymatic activity of fucoidanase was considerably reduced after prolonged (about 60 min) incubation of the enzyme solution at 45 °C. The fucoidanase catalyzed the hydrolysis of fucoidans from Fucus evanescens and Fucus vesiculosus, but not from Saccharina cichorioides. The fucoidanase also did not hydrolyze carrageenan. Desulfated fucoidan from F. evanescens was hydrolysed very weakly in contrast to deacetylated fucoidan, which was hydrolysed more actively compared to the native fucoidan from F. evanescens. Analysis of the structure of the enzymatic products showed that the marine bacteria, F. algae, synthesized an α-l-fucanase with an endo-type action that is specific for 1→4-bonds in a polysaccharide molecule built up of alternating three- and four-linked α-l-fucopyranose residues sulfated mainly at position 2.

1 November 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RURoza Usoltseva
Roza Usoltseva
SAStanislav D. Anastyuk
Stanislav D. Anastyuk
NSNatalia M. Shevchenko
Natalia M. Shevchenko
VSValerii V. Surits
Valerii V. Surits
ASArtem Silchenko
Artem Silchenko
SESvetlana P. Ermakova
Svetlana P. Ermakova

1 February 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
SAStanislav D. Anastyuk
Stanislav D. Anastyuk
NSNatalia M. Shevchenko
Natalia M. Shevchenko
R(Roza V. Usoltseva (Menshova)
Roza V. Usoltseva (Menshova)
ASArtem Silchenko
Artem Silchenko
PZPavel A. Zadorozhny
Pavel A. Zadorozhny
SESvetlana P. Ermakova
Svetlana P. Ermakova

1 August 2018 in Carbohydrate Polymers
Verified
Journal Article
Closed access
ASArtem Silchenko
Artem Silchenko
ARAnton B. Rasin
Anton B. Rasin
MKMikhail Kusaykin
Mikhail Kusaykin
OMOlesya Malyarenko
Olesya Malyarenko
NSNatalie M. Shevchenko
Natalie M. Shevchenko
SESvetlana Ermakova
Svetlana Ermakova